United Therapeutics | UTHR - Net Income


United Therapeutics reported $338.7M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Amarin USD -7.74M 6.4M Sep/2025
Ardelyx USD -969K 18.11M Sep/2025
Baxter International USD -1.13B 1.08B Dec/2025
Bayer EUR -963M 764M Sep/2025
BioCryst Pharmaceuticals USD -88.88M 74.85M Dec/2024
Biogen USD 466.5M 168.3M Sep/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Insmed USD -328.48M 41.54M Dec/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
J&J USD 5.12B 36M Dec/2025
Lexicon Pharmaceuticals USD -53.43M 5.03M Jun/2024
Moderna USD -200M 625M Sep/2025
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
United Therapeutics USD 338.7M 29.2M Sep/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025